Renee Tholey

Sulfur [ ¹⁸ F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis

PARP inhibitors: Synthetic lethality in the clinic

The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

Deubiquitylating enzymes and drug discovery: emerging opportunities

The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma

The Long-Term Outcomes of Wait-and-Scan and the Role of Radiotherapy in the Management of Vestibular Schwannomas

PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery

Muc1 promotes migration and lung metastasis of melanoma cells.

A bulky glycocalyx fosters metastasis formation by promoting G1 cell cycle progression

Clinical Practice Guideline: Sudden Hearing Loss (Update)

Targeting PARP-1 Allosteric Regulation Offers Therapeutic Potential against Cancer

Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11 (USP11) and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival

Clinical, Radiographic, and Audiometric Predictors in Conservative Management of Vestibular Schwannoma

MUC1 Promoter–Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer